Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca

This publication has 31 references indexed in Scilit: